Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) traded down 0.4% during trading on Tuesday . The stock traded as low as €26.90 ($29.24) and last traded at €27.33 ($29.71). 5,130,000 shares traded hands during trading, The stock had previously closed at €27.43 ($29.82).
Bayer Aktiengesellschaft Stock Performance
The firm has a market capitalization of $26.85 billion, a PE ratio of -9.14, a P/E/G ratio of 36.39 and a beta of 0.97. The company has a debt-to-equity ratio of 136.06, a current ratio of 1.27 and a quick ratio of 0.72. The firm has a fifty day moving average price of €27.81 and a 200 day moving average price of €33.90.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Read More
- Five stocks we like better than Bayer Aktiengesellschaft
- Stock Analyst Ratings and Canadian Analyst Ratings
- 4 Golden Crosses With Double-Digit Upside Ahead
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- All-Aboard! Greenbrier Companies Breaks Out, New Highs Ahead
- 5 discounted opportunities for dividend growth investors
- 3 High Dividend Socks to Replace Lower Savings Yields Ahead
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
